LEMBOREXANT vs LENACAPAVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEMBOREXANT vs LENACAPAVIR: Safety Overview
| Metric | LEMBOREXANT | LENACAPAVIR |
|---|---|---|
| Total FAERS Reports | 989 | 502 |
| Deaths Reported | 44 | 32 |
| Death Rate | 4.4% | 6.4% |
| Hospitalizations | 278 | 42 |
| Average Patient Age | 58.9 yrs | 50.0 yrs |
| % Female Patients | 63.4% | 24.7% |
| FDA Approval Date | Apr 7, 2020 | Dec 22, 2022 |
| Manufacturer | Eisai Inc. | Gilead Sciences, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |